Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
about
Receptor heteromerization and drug discovery.Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and functionOpioid receptor heteromers in analgesiaOpioid-induced cardioprotectionG protein-coupled receptors: what a difference a 'partner' makesOpposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and traffickingTranscriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat.Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric refluxOligomerization of G-protein-coupled receptors: a realityChaperoning G protein-coupled receptors: from cell biology to therapeuticsOpioid-receptor-heteromer-specific trafficking and pharmacology.Alterations of CXCR4 function in μ-opioid receptor-deficient glia.Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural informationDopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization.Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.A Pluridimensional View of Biased Agonism.Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptorsHeteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.Recent advances on the δ opioid receptor: from trafficking to function.In vivo opioid receptor heteromerization: where do we stand?Prolonged morphine treatment alters δ opioid receptor post-internalization traffickingHeteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor traffickingG protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding.Escorts take the lead molecular chaperones as therapeutic targetsCXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.Receptor-transporting protein 1 short (RTP1S) mediates translocation and activation of odorant receptors by acting through multiple stepsAdrenocorticotropic Hormone (ACTH) Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane.Receptor-transporting protein (RTP) family members play divergent roles in the functional expression of odorant receptors.Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.Analgesia and central side-effects: two separate dimensions of morphine response.Molecular mechanisms of opioid receptor-dependent signaling and behavior.Molecular Pharmacology of δ-Opioid Receptors.Enhancement of the surface expression of G protein-coupled receptors.Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuliG Protein-Coupled Receptor Heteromers.Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines.Effect of anchoring 4-anilidopiperidines to opioid peptides.Fine-tuning of GPCR activity by receptor-interacting proteinsG-protein-coupled heteromers: regulation in diseaseTwo intracellular helices of G-protein coupling receptors could generally support oligomerization and coupling with transducers.
P2860
Q24631740-7CFA85D6-F57C-4C9C-BE32-0983EC0D6C90Q26992192-DB6ED840-1115-44A0-A0F8-47CEC8F0CE71Q27004306-B704B242-3796-47ED-B3C7-708C20F1C6CFQ27006830-08F26FD5-D265-4BA5-801F-23D809B662B4Q27023482-3E034B54-58E5-4DED-9F32-DF003B88D36DQ28248884-5C0C17F5-ABA8-48D8-A03E-ACEBCF7AEB40Q28488809-05397226-65E1-4B58-A2B9-7BDB7CEB9CE0Q33562267-5C92205B-3350-4343-A18E-F5F580147F05Q33674800-278E98C2-9E58-4185-9AD2-F9E50DE52D1FQ33927508-C56D7086-1B6B-4214-B7A4-863418DE29B7Q33978499-681BB838-F0C0-4DEA-B1C5-F03DF0096F5FQ34209473-9C373EF4-0666-410E-9FD9-F2C892FFA5A7Q34243587-6FA0EE5B-E5F2-4369-A1A1-AC0A65145574Q34344881-8B911BFF-1105-4EBD-9D23-ECC4A0094EADQ34424009-8C202399-5F81-4438-B9DB-78D48E4C7591Q34540545-A2F129E5-6B2B-4CD0-9902-41B185AA7297Q34767171-A1C47523-36B8-4B82-BD92-281E7A554E4BQ34939624-8DCB1498-9378-4575-993C-ADCBFD867DB9Q34939664-39F245AE-41F8-4245-BC25-4B2BDADB6FCEQ34939677-BE3B544E-33DC-4AC2-8D26-3501448F9153Q34939888-808BE594-250C-4583-A2B9-D9CBF2E36396Q34989880-94ECD504-3C8A-440F-A200-D16BAEFC71C9Q35008902-4E2F7FAC-45A5-4937-8512-C19DD48B755FQ35075365-FDC80043-F776-4A76-9B6B-43A1E29137CBQ35213405-4986DD46-0EA5-4A37-9258-F393977D3423Q36052551-45B65A9C-13C6-45B5-BF12-8A45E6E43806Q36282960-46F3C29F-BE55-429F-89ED-787FBE6C9D2CQ36394035-36284955-14DB-46E0-8D43-7CBAFCBB3B10Q36438816-B2D8B813-BC5A-4765-BE90-5360F8F98247Q36792999-8A5B3FDE-1180-4AD1-8E5C-391658187ACFQ36974487-1A9AC0CC-CB25-4FEF-B269-413E40A09E2EQ37062556-B6433F7C-1627-483E-AEB9-7E0A085436EFQ37316198-B3683C19-8CBB-4C3B-859D-1304D452240DQ37360341-4E0E7811-042C-419E-9F4A-D0AF97939980Q37489251-B53CB175-535E-4F2A-A2D2-3CD602B6FC88Q37605998-34F4E8B4-1AC5-4BCC-8784-3BC712453DA2Q37617253-98F9E4A5-8071-479D-9CF2-5713EBAF1593Q37638132-096ADA91-E200-49AA-B0B1-6177EBE2A343Q37686142-C52EA248-0DF0-4361-A2C1-3FC51DAF7440Q37767164-79611274-EBEC-47A6-B586-734E8A9CEA20
P2860
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
@en
type
label
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
@en
prefLabel
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
@en
P2093
P2860
P356
P1476
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.
@en
P2093
Achla Gupta
Fabien M Décaillot
Lakshmi A Devi
Raphael Rozenfeld
P2860
P304
16045-16050
P356
10.1073/PNAS.0804106105
P407
P577
2008-10-03T00:00:00Z